Suchergebnisse - "Park, Sojung"

PubPharm (6)

1

Direct potentiation of NK cell cytotoxicity by 8-azaguanine with potential antineoplastic activity

enthalten in: International immunopharmacology | 2019

von Kim, N. | Choi, J. | Song, A. | +5

2

Non-Small Cell Lung Cancer with Resistance to EGFR-TKI Therapy : CT Characteristics of T790M Mutation-positive Cancer

enthalten in: Radiology | 2018

von Koo, H. | Kim, M. | Park, S. | +6

CommentIn: J Thorac Dis. 2018 Nov;10(Suppl 33):S4113-S4116. - PMID 30631569

3

Genomics of drug sensitivity in bladder cancer : an integrated resource for pharmacogenomic analysis in bladder cancer

enthalten in: BMC medical genomics | 2018

von Ansari, A. | Park, I. | Kim, I. | +3

4

Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production

enthalten in: Cancer letters | 2016

von Seol, H. | Lee, S. | Song, J. | +6

5

Activation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer

enthalten in: Oncotarget | 2016

von Park, J. | Choi, Y. | Kim, S. | +9

6

Survival Benefit of Pemetrexed in Lung Adenocarcinoma Patients With Anaplastic Lymphoma Kinase Gene Rearrangements

enthalten in: Clinical lung cancer | 2015

von Park, S. | Park, T. | Choi, C. | +6

1
[1]